Warsaw, Poland – June 03, 2026 – JJP Biologics, ("JJPBio" or the "Company") a clinical-stage, immune-focused biotech that engineers precision antibodies to correct derailed immune pathways that drive autoimmune diseases and cancer, today announces positive interim data from its ongoing Phase 1b trial evaluating nebaprubart, also known as JJP-1212, its investigational potential first-in-class anti-CD89 antagonist, in patients diagnosed with Linear IgA Disease (LAD), a rare autoantibody-mediated skin disease.
YOKOHAMA, Japan, June 3, 2026 /PRNewswire/ -- Visteon Corporation (NASDAQ: VC), a global leader in automotive cockpit electronics, today announced that its 12.3-inch Narrow...
Between 2018 and 2023, Dr Ivan Puah treated over 550 cases, addressing unique challenges in Singapore's multi-ethnic population. His study included diverse case profiles....
Continued design innovation on the pioneering ergonomic seating icon supports the changing ways people work and live ZEELAND, Mich., June 3, 2026 /PRNewswire/ -- Herman...
BANGKOK, June 3, 2026 /PRNewswire/ -- Daesang strengthened its global brand presence through an integrated booth featuring Jongga, Ofood, and Mamasuka at THAIFEX-Anuga Asia...
/NOT FOR DISSEMINATION IN THE U.S. OR THROUGH U.S. NEWSWIRES/CALGARY, AB, June 2, 2026 /CNW/ - Highwood Asset Management Ltd. ("Highwood" or the "Company")...
IRVINE, Calif., June 2, 2026 /PRNewswire-HISPANIC PR WIRE/ -- Today Hyundai Motor Group Metaplant America (HMGMA) and Kia America (KUS) celebrated the start of...
BBNX Shareholder Alert: Robbins LLP Reminds Beta Bionics, Inc. Stockholders that it is Investigating the Company's Officers and Directors to Determine if T
IRVINE, Calif., June 2, 2026 /PRNewswire/ -- Today Hyundai Motor Group Metaplant America (HMGMA) and Kia America (KUS) celebrated the start of production for...
Eletre X is built for drivers who refuse to compromise - delivering ultimate performance, 1,200+ km of range, and 9-minute charging in a practical hybrid SUV.1 Available to order today, starting from €96,990.